On Oct 24, major Wall Street analysts update their ratings for $Thermo Fisher Scientific (TMO.US)$, with price targets ranging from $610 to $718.
BofA Securities analyst Michael Ryskin maintains with a buy rating, and sets the target price at $675.
Barclays analyst Luke Sergott maintains with a hold rating, and maintains the target price at $610.
Wells Fargo analyst Brandon Couillard maintains with a buy rating, and adjusts the target price from $670 to $660.
Jefferies analyst Tycho Peterson maintains with a buy rating, and maintains the target price at $655.
TD Cowen analyst Daniel Brennan maintains with a buy rating, and maintains the target price at $686.
Furthermore, according to the comprehensive report, the opinions of $Thermo Fisher Scientific (TMO.US)$'s main analysts recently are as follows:
Thermo Fisher's recent quarterly report met expectations in a climate where anticipation was high. The company has demonstrated strong execution despite challenging conditions and uncertain timing for a demand resurgence in the tools sector.
The firm notes that Thermo Fisher's core growth is showing consistent improvement on a quarter-over-quarter basis, with projections hinting at a slight increase to approximately +2.5% in Q4. The expectations of a 5% core growth by 2025 also appear to be reasonable and justifiable. The firm expresses its preference for Thermo Fisher's resilient nature and the flexibility provided by its balance sheet.
The firm mentioned that Thermo Fisher presented a mixed set of results for the third quarter, with revenue falling just short of the general consensus but surpassing expectations on earnings. Management described the market conditions as matching their forecasts, with slight enhancements and steadiness observed throughout their range of offerings.
Here are the latest investment ratings and price targets for $Thermo Fisher Scientific (TMO.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月24日，多家華爾街大行更新了$賽默飛世爾 (TMO.US)$的評級，目標價介於610美元至718美元。
美銀證券分析師Michael Ryskin維持買入評級，目標價675美元。
巴克萊銀行分析師Luke Sergott維持持有評級，維持目標價610美元。
富國集團分析師Brandon Couillard維持買入評級，並將目標價從670美元下調至660美元。
富瑞集團分析師Tycho Peterson維持買入評級，維持目標價655美元。
TD Cowen分析師Daniel Brennan維持買入評級，維持目標價686美元。
此外，綜合報道，$賽默飛世爾 (TMO.US)$近期主要分析師觀點如下：
Thermo Fisher最近的季度報告符合市場預期，儘管預期值較高。該公司在困難條件和需求在工具板塊復甦的時機不確定的情況下，展現了強大的執行力。
該公司指出，Thermo Fisher的核心增長在季度基礎上持續改善，預計第四季度將略微增長約+2.5%。到2025年，預期核心增長達到5%看起來也是合理且具備可信性的。公司表達了對Thermo Fisher堅韌性質和其資產負債表提供的靈活性的偏好。
該公司提到，Thermo Fisher在第三季度呈現了一套複雜的結果，營業收入略低於一般共識，但盈利超過預期。管理層描述市場狀況與他們的預測相匹配，在他們的產品範圍內觀察到了輕微的改善和穩定。
以下爲今日8位分析師對$賽默飛世爾 (TMO.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
